KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+19.13%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$1.29B
AUM Growth
+$1.29B
(+35%)
Cap. Flow
+$188M
Cap. Flow
% of AUM
14.56%
Top 10 Holdings %
Top 10 Hldgs %
82.4%
Holding
28
New
2
Increased
17
Reduced
4
Closed
–
Top Buys
| 1 |
CG Oncology
CGON
|
$64.8M |
| 2 |
Vaxcyte
PCVX
|
$32.7M |
| 3 |
Beam Therapeutics
BEAM
|
$31.9M |
| 4 |
Viridian Therapeutics
VRDN
|
$17.3M |
| 5 |
Dynavax Technologies
DVAX
|
$13.9M |
Top Sells
| 1 |
Protagonist Therapeutics
PTGX
|
$15.5M |
| 2 |
Travere Therapeutics
TVTX
|
$9.1M |
| 3 |
Tyra Biosciences
TYRA
|
$2.32M |
| 4 |
Cogent Biosciences
COGT
|
$223K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Insmed
INSM
$28.8B
| – | – |
0
| – | – |
|
27
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
28
Vertex Pharmaceuticals
VRTX
$100B
| – | – |
0
| – | – |
|